Proceedings of the National Academy of Sciences · 1992 · 28 citations · 32 references
MedicineCell BiologyOncologyCarcinogenesisNeoplasiaTumor ProgressionAnimal Cell CultureChemical CarcinogenesisMalignant NeoplasmsFibroblast CultureFocusGrowth FactorsSerum-free AdaptationSerum-free CultureSerum-free Media
Treatment of MSU-1.1 cells, a near-diploid, karyotypically stable, infinite life-span human fibroblast strain, with (+-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induced focus formation. Eight independent foci were isolated and the cell strains developed from them were examined for characteristics of malignant cells. Each grew to a higher density in medium containing 1% serum than did the MSU-1.1 cells. Three of the eight grew rapidly in serum-free medium without added growth factors, formed colonies in agarose with diameters of greater than or equal to 120 microns at a frequency of 5-19%, exhibited loss of genetic material, and, when injected into athymic mice, formed sarcomas that reached 6 mm in diameter within 2-3 wk. One produced high-grade sarcomas (progressively growing, invasive tumors exhibiting high mitotic activity); the other two produced low-grade sarcomas (tumors with a lower degree of mitotic activity) that developed focal areas of high-grade malignant cells if left in the animals for greater than 4 wk. A fourth cell strain formed high-grade sarcomas only after 2.5-3 mo, but the tumor-derived cells analyzed showed the same growth properties as the three malignant cell strains described above, exhibited loss of genetic material, and, when reinjected into athymic mice, produced high-grade sarcomas with a short latency period.
32
Sir Richard Doll · Cancer · 1980 · 568 citations · Full text
José Costa, Robert Wesley, Eli Glatstein et al. · Cancer · 1984 · 511 citations · Full text
Mechanisms of p53 loss in human sarcomas.
Lois M. Mulligan, Greg Matlashewski, Heidi Scrable et al. · Proceedings of the National Academy of Sciences · 1990 · 273 citations
Life Sciences, Genetics, Oncology +15